V

Verastem
D

VSTM

3.92000
USD
0.13
(3.43%)
Market Closed
Volume
0
EPS
-3
Div Yield
-
P/E
-1
Market Cap
157,755,480
OverviewSignalsIdeasNews
Related Instruments
    A
    ADMA
    -1.180
    (-5.84%)
    19.030 USD
    C
    CTMX
    -0.08670
    (-8.67%)
    0.91330 USD
    E
    EXEL
    -0.600
    (-1.71%)
    34.450 USD
    I
    IMMP
    -0.02000
    (-0.96%)
    2.06000 USD
    I
    IONS
    -2.970
    (-7.97%)
    34.290 USD
    M
    MNOV
    0.04000
    (2.17%)
    1.88000 USD
    S
    SGEN
    0
    (0%)
    0.000000 USD
    T
    TGTX
    -1.325
    (-4.30%)
    29.515 USD
    More
News

Title: Verastem

Sector: Healthcare
Industry: Biotechnology
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer thatpromote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.